205 related articles for article (PubMed ID: 29218249)
1. Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.
Reid JC; Matsika A; Davies CM; He Y; Broomfield A; Bennett NC; Magdolen V; Srinivasan B; Clements JA; Hooper JD
Am J Cancer Res; 2017; 7(11):2257-2274. PubMed ID: 29218249
[TBL] [Abstract][Full Text] [Related]
2. Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer.
Lisle JE; Mertens-Walker I; Stephens CR; Stansfield SH; Clements JA; Herington AC; Stephenson SA
Exp Cell Res; 2015 Apr; 333(1):136-46. PubMed ID: 25724897
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1.
Fuhrman-Luck RA; Stansfield SH; Stephens CR; Loessner D; Clements JA
J Proteome Res; 2016 Aug; 15(8):2466-78. PubMed ID: 27378148
[TBL] [Abstract][Full Text] [Related]
4. The roles of proteases in prostate cancer.
Koistinen H; Kovanen RM; Hollenberg MD; Dufour A; Radisky ES; Stenman UH; Batra J; Clements J; Hooper JD; Diamandis E; Schilling O; Rannikko A; Mirtti T
IUBMB Life; 2023 Jun; 75(6):493-513. PubMed ID: 36598826
[TBL] [Abstract][Full Text] [Related]
5. Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cells.
Sanchez WY; de Veer SJ; Swedberg JE; Hong EJ; Reid JC; Walsh TP; Hooper JD; Hammond GL; Clements JA; Harris JM
Endocrinology; 2012 Jul; 153(7):3179-89. PubMed ID: 22547569
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progression.
Ramsay AJ; Dong Y; Hunt ML; Linn M; Samaratunga H; Clements JA; Hooper JD
J Biol Chem; 2008 May; 283(18):12293-304. PubMed ID: 18308730
[TBL] [Abstract][Full Text] [Related]
7. Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.
Shahinian H; Loessner D; Biniossek ML; Kizhakkedathu JN; Clements JA; Magdolen V; Schilling O
Mol Oncol; 2014 Feb; 8(1):68-82. PubMed ID: 24120346
[TBL] [Abstract][Full Text] [Related]
8. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V
Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050
[TBL] [Abstract][Full Text] [Related]
9. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.
Ko CJ; Huang CC; Lin HY; Juan CP; Lan SW; Shyu HY; Wu SR; Hsiao PW; Huang HP; Shun CT; Lee MS
Cancer Res; 2015 Jul; 75(14):2949-60. PubMed ID: 26018085
[TBL] [Abstract][Full Text] [Related]
10. Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression.
Tripathi M; Nandana S; Yamashita H; Ganesan R; Kirchhofer D; Quaranta V
J Biol Chem; 2008 Nov; 283(45):30576-84. PubMed ID: 18784072
[TBL] [Abstract][Full Text] [Related]
11. The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells.
Wilson S; Greer B; Hooper J; Zijlstra A; Walker B; Quigley J; Hawthorne S
Biochem J; 2005 Jun; 388(Pt 3):967-72. PubMed ID: 15537383
[TBL] [Abstract][Full Text] [Related]
12. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma.
Lucas JM; True L; Hawley S; Matsumura M; Morrissey C; Vessella R; Nelson PS
J Pathol; 2008 Jun; 215(2):118-25. PubMed ID: 18338334
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.
Limburg H; Harbig A; Bestle D; Stein DA; Moulton HM; Jaeger J; Janga H; Hardes K; Koepke J; Schulte L; Koczulla AR; Schmeck B; Klenk HD; Böttcher-Friebertshäuser E
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391268
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-Related Peptidase 14 Activates Zymogens of Membrane Type Matrix Metalloproteinases (MT-MMPs)-A CleavEx Based Analysis.
Falkowski K; Bielecka E; Thøgersen IB; Bocheńska O; Płaza K; Kalińska M; Sąsiadek L; Magoch M; Pęcak A; Wiśniewska M; Gruba N; Wysocka M; Wojtysiak A; Brzezińska-Bodal M; Sychowska K; Pejkovska A; Rehders M; Butler G; Overall CM; Brix K; Dubin G; Lesner A; Kozik A; Enghild JJ; Potempa J; Kantyka T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575583
[TBL] [Abstract][Full Text] [Related]
15. Roles and regulation of membrane-associated serine proteases.
Qiu D; Owen K; Gray K; Bass R; Ellis V
Biochem Soc Trans; 2007 Jun; 35(Pt 3):583-7. PubMed ID: 17511657
[TBL] [Abstract][Full Text] [Related]
16. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.
Dong Y; Bui LT; Odorico DM; Tan OL; Myers SA; Samaratunga H; Gardiner RA; Clements JA
Endocr Relat Cancer; 2005 Dec; 12(4):875-89. PubMed ID: 16322328
[TBL] [Abstract][Full Text] [Related]
17. Interdependence of kallikrein-related peptidases in proteolytic networks.
Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
[TBL] [Abstract][Full Text] [Related]
18. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia.
Afar DE; Vivanco I; Hubert RS; Kuo J; Chen E; Saffran DC; Raitano AB; Jakobovits A
Cancer Res; 2001 Feb; 61(4):1686-92. PubMed ID: 11245484
[TBL] [Abstract][Full Text] [Related]
19. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
Mukai S; Fukushima T; Naka D; Tanaka H; Osada Y; Kataoka H
FEBS J; 2008 Mar; 275(5):1003-17. PubMed ID: 18221492
[TBL] [Abstract][Full Text] [Related]
20. Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion.
Tervonen TA; Belitškin D; Pant SM; Englund JI; Marques E; Ala-Hongisto H; Nevalaita L; Sihto H; Heikkilä P; Leidenius M; Hewitson K; Ramachandra M; Moilanen A; Joensuu H; Kovanen PE; Poso A; Klefström J
Oncogene; 2016 Apr; 35(14):1832-46. PubMed ID: 26165838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
